Combining TIGIT blockade with IL‐15 stimulation is a promising immunotherapy strategy for lung adenocarcinoma.

Saved in:
Bibliographic Details
Title: Combining TIGIT blockade with IL‐15 stimulation is a promising immunotherapy strategy for lung adenocarcinoma.
Authors: Luo, Baohong1 (AUTHOR), Sun, Yu1,2 (AUTHOR), Zhan, Qinru1,2 (AUTHOR), Luo, Yuting1,2 (AUTHOR), Chen, Yu2,3 (AUTHOR), Fu, Tongze1,2 (AUTHOR), Yang, Tiantian1,2 (AUTHOR), Ren, Lijuan1,2 (AUTHOR), Xie, Zhongpeng1,2 (AUTHOR), Situ, Xiaohua1,2 (AUTHOR), Liu, Bixia1 (AUTHOR), Tang, Kejing4 (AUTHOR) tangkj@mail.sysu.edu.cn, Ke, Zunfu1,2 (AUTHOR) kezunfu@mail.sysu.edu.cn
Source: Clinical & Translational Medicine. Jan2024, Vol. 14 Issue 1, p1-20. 20p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20011326
DOI:10.1002/ctm2.1553